Author: Guella, Adnane; Elfadil, Osman; Abdulrazaq, Ghisson; Osman, Sahla; Khan, Mohammed Munir; Ahmed, Abdalla; Deyab, Feras
Title: Favorable Outcome of COVID-19 Pneumonia in a Kidney Transplant Recipient Treated with Tocilizumab Cord-id: 343y0bsh Document date: 2020_9_16
ID: 343y0bsh
Snippet: The presentation of COVID-19 pneumonia in kidney transplant recipients is similar to that of the general population. However, in the former, it may have a worse clinical course. We report a kidney transplant patient affected by COVID-19 pneumonia whose condition worsened 9 days after the initial presentation. As no therapeutic guidelines on the subject are currently available, here we share our approach in the management of the immunosuppressive medications and the antiviral therapy and compare
Document: The presentation of COVID-19 pneumonia in kidney transplant recipients is similar to that of the general population. However, in the former, it may have a worse clinical course. We report a kidney transplant patient affected by COVID-19 pneumonia whose condition worsened 9 days after the initial presentation. As no therapeutic guidelines on the subject are currently available, here we share our approach in the management of the immunosuppressive medications and the antiviral therapy and compare them to the scarce available data. We also expose the use of tocilizumab in our patient with excellent results.
Search related documents:
Co phrase search for related documents- admission time and lymphocyte leucocyte: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date